Ebglyss 250 mg/2 mL injection Images

Generic Name: lebrikizumab

This medication has been identified as Ebglyss 250 mg/2 mL injection. It is supplied by Eli Lilly and Company.

Ebglyss is used in the treatment of Atopic Dermatitis and belongs to the drug class interleukin inhibitors. Ebglyss 250 mg/2 mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Ebglyss

Generic Name

lebrikizumab

Strength

250 mg/2 mL injection

Availability

Prescription only

Drug Class

Interleukin inhibitors

CSA Schedule

Not a controlled drug

Labeler / Supplier

Eli Lilly and Company

National Drug Code (NDC)

multiple

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer